The Evolution of Biologics Administration From Intravenous to Subcutaneous: Treatments for Inflammatory Bowel Disease Go Home

Gastroenterology. 2021 Jun;160(7):2244-2247. doi: 10.1053/j.gastro.2021.03.038. Epub 2021 Mar 25.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Administration, Intravenous
  • Biological Products* / adverse effects
  • Colitis*
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy

Substances

  • Biological Products